SEC: Insider Trading Ring Led to $1.7M in Illegal Profits
According to the SEC, an insider trading ring based out of Celgene Corp., Sanofi SA and Stryker Corp. was counting on a lack of resources for enforcement at the agency to evade discovery. Those hopes were dashed Monday.
Sign up for Perspectives FREE e-mail newsletter.
Outside the U.S.: 1-404-262-5423
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST